Basit öğe kaydını göster

dc.contributor.authorKoksal M.
dc.contributor.authorBilge S.S.
dc.contributor.authorBozkurt A.
dc.contributor.authorSahin Z.S.
dc.contributor.authorIsik S.
dc.contributor.authorErol D.D.
dc.date.accessioned2020-06-21T09:24:23Z
dc.date.available2020-06-21T09:24:23Z
dc.date.issued2008
dc.identifier.issn0004-4172
dc.identifier.urihttps://hdl.handle.net/20.500.12712/3797
dc.descriptionPubMed: 19025061en_US
dc.description.abstractSeveral 5-(3,4-dichlorophenyl)-2-(aroylmethyl)thio-1,3,4-oxadiazoles were synthesized and characterized by elemental analyses, IR and nuclear magnetic resonance spectra. All compounds were evaluated for anti-inflammatory activity by determining their ability to provide protection against carregeenan-induced edema in rat paw. In addition, ulcerogenic activity was determined. The anti-inflammatory data scoring showed that compounds 5e, 5f and 5g, at the dose of 100 mg/kg, exhibited anti-inflammatory activity, which for compound 5f was comparable to that of the reference drug indometacin (CAS 53-86-1). © ECV Editio Cantor Verlag.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject1,3,4-oxadiazoles, antiinflammatory activity, S-alkylation, synthesis, X-ray crystallographyen_US
dc.titleSynthesis, characterization and anti-inflammatory activity of new 5- (3,4-dichlorophenyl)-2-(aroylmethyl) thio-1,3,4-oxadiaxolesen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume58en_US
dc.identifier.issue10en_US
dc.identifier.startpage510en_US
dc.identifier.endpage514en_US
dc.relation.journalArzneimittel-Forschung/Drug Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster